Frontline management of mantle cell lymphoma.
Ryan CE, Armand P, LaCasce AS.
Blood. 2025 Feb 13;145(7):663-672. doi: 10.1182/blood.2023022352.
Mantle cell lymphoma-Update on molecular biology, prognostication and treatment approaches.
Silkenstedt E, Dreyling M.
Hematol Oncol. 2023 Jun;41 Suppl 1:36-42. doi: 10.1002/hon.3149.
Molecular Pathogenesis of Mantle Cell Lymphoma.
Navarro A, Beà S, Jares P, Campo E.
Hematol Oncol Clin North Am. 2020 Oct;34(5):795-807. doi: 10.1016/j.hoc.2020.05.002. Epub 2020 Jul 22.
Blastoid Mantle Cell Lymphoma.
Jain P, Wang M.
Hematol Oncol Clin North Am. 2020 Oct;34(5):941-956. doi: 10.1016/j.hoc.2020.06.009. Epub 2020 Aug 5.
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
Jain P, Wang M.
Am J Hematol. 2019 Jun;94(6):710-725. doi: 10.1002/ajh.25487. Epub 2019 Apr 19.
New Directions for Mantle Cell Lymphoma in 2022.
Kumar A, Eyre TA, Lewis KL, Thompson MC, Cheah CY.
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-15. doi: 10.1200/EDBK_349509.
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline.
Eyre TA, Bishton MJ, McCulloch R, O'Reilly M, Sanderson R, Menon G, Iyengar S, Lewis D, Lambert J, Linton KM, McKay P; Haemato-Oncology Task Force of the British Society for Haematology.
Br J Haematol. 2024 Jan;204(1):108-126. doi: 10.1111/bjh.19131. Epub 2023 Oct 25.
Mantle-cell lymphoma.
Barista I, Romaguera JE, Cabanillas F.
Lancet Oncol. 2001 Mar;2(3):141-8. doi: 10.1016/S1470-2045(00)00255-2.
Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma.
López C, Silkenstedt E, Dreyling M, Beà S.
Blood Adv. 2024 Jul 23;8(14):3652-3664. doi: 10.1182/bloodadvances.2023011763.
Mantle Cell Lymphoma: Which Patients Should We Transplant?
Gerson JN, Barta SK.
Curr Hematol Malig Rep. 2019 Aug;14(4):239-246. doi: 10.1007/s11899-019-00520-0.
